Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van Dam, Koos P JWieske, Luuk
Stalman, Eileen W
Kummer, Laura Y L
Roosen, Jesse
van Kempen, Zoé L E
Killestein, Joep
Volkers, Adriaan G
Boekel, Laura
Wolbink, Gerrit J
van der Kooi, Anneke J
Raaphorst, Joost
Löwenberg, Mark
Takkenberg, R Bart
D'Haens, Geert R A M
Spuls, Phyllis I
Bekkenk, Marcel W
Musters, Annelie H
Post, Nicoline F
Bosma, Angela L
Hilhorst, Marc L
Vegting, Yosta
Bemelman, Frederike J
Voskuyl, Alexandre E
Broens, Bo
Sanchez, Agner Parra
van Els, Cécile A C M
de Wit, Jelle
Rutgers, Abraham
de Leeuw, Karina
Horváth, Barbara
Verschuuren, Jan J G M
Ruiter, Annabel M
van Ouwerkerk, Lotte
van der Woude, Diane
Allaart, Renée C F
Teng, Y K Onno
van Paassen, Pieter
Busch, Matthias H
Jallah, Papay B P
Brusse, Esther
van Doorn, Pieter A
Baars, Adája E
Hijnen, Dirk Jan
Schreurs, Corine R G
van der Pol, W Ludo
Goedee, H Stephan
Steenhuis, Maurice
Keijzer, Sofie
Keijser, Jim B D
Cristianawati, Olvi
Rispens, Theo
Brinke, Anja Ten
Verstegen, Niels J M
Marieke van Ham, S
Tas, Sander W
Kuijpers, Taco W
Eftimov, Filip
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.Published in
Journal of autoimmunity 2023;135:102984PMID
36621174ae974a485f413a2113503eed53cd6c53
10.1016/j.jaut.2022.102984
Scopus Count
Collections
Related articles
- Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
- Authors: Boekel L, Stalman EW, Wieske L, Hooijberg F, van Dam KPJ, Besten YR, Kummer LYL, Steenhuis M, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Vogelzang EH, Leeuw M, Atiqi S, van Vollenhoven R, Gerritsen M, van der Horst-Bruinsma IE, Lems WF, Nurmohamed MT, Boers M, Keijzer S, Keijser J, van de Sandt C, Boogaard A, Cristianawati O, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Rispens T, Kuijpers TW, Wolbink G, Eftimov F, T2B! immunity against SARS-CoV-2 study group
- Issue date: 2022 Jun
- An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
- Authors: Isnardi CA, Schneeberger EE, Kreimer JL, Luna PC, Echeverría C, Roberts K, de la Vega MC, Virasoro BM, Landi M, Quintana R, Exeni MED, Kogan N, Petkovic I, Pereira D, De Los Ángeles Correa M, Zelaya MD, Tissera Y, Elkin MSG, Pisoni CN, Alonso C, Cogo AK, Cosatti MA, García L, Retamozo C, de Los Ángeles Severina M, Nieto RE, Rosemffet M, Mussano E, Bertoli A, Savio VG, Cosentino V, Pons-Estel GJ
- Issue date: 2022 Oct
- Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
- Authors: Wieske L, Kummer LYL, van Dam KPJ, Stalman EW, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, Volkers AG, D'Haens GRAM, Tas SW, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Killestein J, van Kempen ZLE, Voskuyl AE, Broens B, Sanchez AP, Wolbink G, Boekel L, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart CF, Teng YKO, van Paassen P, Busch MH, Jallah BP, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Rispens T, Ten Brinke A, Verstegen NJM, Zwinderman KAH, van Ham SM, Kuijpers TW, Eftimov F, T2B! immunity against SARS-CoV-2 study group
- Issue date: 2022 Mar 2
- Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares.
- Authors: Carubbi F, Alunno A, Santilli J, Natali L, Mancini B, Di Gregorio N, Del Pinto R, Viscido A, Grassi D, Ferri C
- Issue date: 2022 Sep
- Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series.
- Authors: Kaulen LD, Doubrovinskaia S, Mooshage C, Jordan B, Purrucker J, Haubner C, Seliger C, Lorenz HM, Nagel S, Wildemann B, Bendszus M, Wick W, Schönenberger S
- Issue date: 2022 Feb